Merck & Co. ranks among the top dividend contenders, having increased payouts for 14 consecutive years. Dividend stocks ...

Top 15. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other top dividend ...

US pharma giant Merck & Co (NYSE: MRK) has presented positive results from two pivotal Phase III trials of the ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other ...

Q4 2024 Results Conference Call March 6, 2025 8:00 AM ETCompany ParticipantsFlorian Schraeder - Head of Investor ...

Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

There are fundamental differences between commercial and residential real estate investing and each has unique advantages and challenges that cater to different investor profiles. Understanding ...

Merck, also known as MSD outside the U.S. and Canada, plans to significantly expand its workforce in India, aiming for around 2,700 employees by the year's end. The company focuses on therapy areas ...

RUPERT -- Merck Forest & Farmland Center (MFFC) announces the appointment of Tom O’Handley as its new Senior Director of Development. His leadership comes at a pivotal time as MFFC embarks on its 75th ...

Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...

Merck said that the sBLA is based on data from the Phase III ... patents & legal, executive appointments, commercial strategy and financial results. Daily roundup of key events in pharma and biotech.

Commercial revenues were $86 million in the ... Adjusted operating loss is expected to be less than $495 million. EU Approval to Merck’s Welireg for Two Indications The European Commission ...